Top

Published in:

Open Access 01-04-2020 | Original Article

Myocardial bridging is an independent predictor of positive spasm provocation testing by intracoronary ergonovine injections: a retrospective observational study

Authors: Riku Arai, Hiroto Kano, Shinya Suzuki, Hiroaki Semba, Takuto Arita, Naoharu Yagi, Takayuki Otsuka, Shunsuke Matsuno, Minoru Matsuhama, Yuko Kato, Tokuhisa Uejima, Yuji Oikawa, Yasuo Okumura, Junji Yajima, Takeshi Yamashita

Published in: Heart and Vessels | Issue 4/2020

Abstract

The relationship between myocardial bridging (MB) and coronary spasms during spasm provocation testing (SPT) remains unclear. We aimed to investigate whether MB was correlated with the SPT by ergonovine (ER) injections in a retrospective observational study. Of the 3340 patients who underwent a first coronary angiography, 166 underwent SPT using ER injections and were divided into 2 groups: MB(+) (n = 23), and MB(−) (n = 143). MB was defined as an angiographic reduction in the diameter of the coronary artery during systole. The patients who had severe organic stenosis in the left anterior descending coronary artery were excluded. The MB(+) group more frequently had diabetes mellitus and chronic kidney disease, and a thicker interventricular septum thickness. The rate of SPT-positivity was higher in the MB(+) group than MB(−) group (56.5% vs. 22.4%, P = 0.001). A multivariate regression analysis showed that the presence of MB was independently associated with SPT-positivity (odds ratio 5.587, 95% confidence interval 2.061–15.149, P = 0.001). In conclusion, coronary spasms during provocation tests with ER independently correlated with the MB. MB may predict coronary spasms.

Tarantini G, Migliore F, Cademartiri F, Fraccaro C, Iliceto S (2016) Left anterior descending artery myocardial bridging: a clinical approach. J Am Coll Cardiol 68:2887–2899CrossRef

Ishikawa Y, Kawawa Y, Kohda E, Shimada K, Ishii T (2011) Significance of the anatomical properties of a myocardial bridge in coronary heart disease. Circ J 75:1559–1566CrossRef

Berry JF, von Mering GO, Schmalfuss C, Hill JA, Kerensky RA (2002) Systolic compression of the left anterior descending coronary artery: a case series, review of the literature, and therapeutic options including stenting. Catheter Cardiovasc Interv 56:58–63CrossRef

Tauth J, Sullebarger T (1997) Myocardial infarction associated with myocardial bridging: case history and review of the literature. Catheter Cardiovasc Diagn 40:364–367CrossRef

Cutler D, Wallace JM (1997) Myocardial bridging in a young patient with sudden death. Clin Cardiol 20:581–583CrossRef

Ural E, Bildirici U, Celikyurt U, Kilic T, Sahin T, Acar E, Kahraman G, Ural D (2009) Long-term prognosis of non-interventionally followed patients with isolated myocardial bridge and severe systolic compression of the left anterior descending coronary artery. Clin Cardiol 32:454–457CrossRef

Kodama K, Morioka N, Hara Y, Shigematsu Y, Hamada M, Hiwada K (1998) Coronary vasospasm at the site of myocardial bridge—report of two cases. Angiology 49:659–663CrossRef

Teragawa H, Fukuda Y, Matsuda K, Hirao H, Higashi Y, Yamagata T, Oshima T, Matsuura H, Chayama K (2003) Myocardial bridging increases the risk of coronary spasm. Clin Cardiol 26:377–383CrossRef

Kim JW, Seo HS, Na JO, Suh SY, Choi CU, Kim EJ, Rha SW, Park CG, Oh DJ (2008) Myocardial bridging is related to endothelial dysfunction but not to plaque as assessed by intracoronary ultrasound. Heart 94:765–769CrossRef

10.

Kim JW, Park CG, Suh SY, Choi CU, Kim EJ, Rha SW, Seo HS, Oh DJ (2007) Comparison of frequency of coronary spasm in Korean patients with versus without myocardial bridging. Am J Cardiol 100:1083–1086. https://doi.org/10.1016/j.amjcard.2007.05.030 CrossRefPubMed

11.

Sara JDS, Corban MT, Prasad M, Prasad A, Gulati R, Lerman LO, Lerman A (2019) The prevalence of myocardial bridging associated with coronary endothelial dysfunction in patients with chest pain and non-obstructive coronary artery disease. EuroIntervention. https://doi.org/10.4244/eij-d-18-00920 CrossRef

12.

Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y (2017) Relation between severity of myocardial bridge and vasospasm. Int J Cardiol 248:34–38CrossRef

13.

Bourassa MG, Butnaru A, Lesperance J, Tardif JC (2003) Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies. J Am Coll Cardiol 41:351–359CrossRef

14.

Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SE, Pepine CJ, Watson RM, Ritchie JL, Gibbons RJ, Cheitlin MD, Gardner TJ, Garson A Jr, Russell RO Jr, Ryan TJ, Smith SC Jr (1999) ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 33:1756–1824CrossRef

15.

(2014) Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013). Circ J 78: 2779–2801

16.

Sueda S, Oshita A, Izoe Y, Kohno H, Fukuda H (2006) Survey of coronary spasm in Japan before the establishment of spasm guidelines: analysis of questionnaires throughout Japan. J Cardiol 48:333–343PubMed

17.

Xiang DC, Gong ZH, He JX, Ruan YJ, Xie ZH (2009) Characteristics of stress tests and symptoms in patients with myocardial bridge and coronary artery spasm. Coron Artery Dis 20:27–31CrossRef

18.

Sueda S, Kohno H (2018) Relationships between more than 90% coronary luminal narrowing induced by ergonovine provocation test and ECG ischemic change as well as chest symptoms. Heart Vessels 33:95–101CrossRef

19.

Koyama T, Tanaka A, Yoshida H, Oyama JI, Toyoda S, Sakuma M, Inoue T, Otsuka Y, Node K (2018) Comparison of the effects of linagliptin and voglibose on endothelial function in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, pilot study (EFFORT). Heart Vessels 33:958–964CrossRef

20.

Tabata N, Hokimoto S, Akasaka T, Arima Y, Sakamoto K, Yamamoto E, Tsujita K, Izumiya Y, Yamamuro M, Kojima S, Kaikita K, Ogawa H (2016) Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients. Heart Vessels 31:1038–1044CrossRef

21.

Yasue H, Touyama M, Shimamoto M, Kato H, Tanaka S (1974) Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina. Circulation 50:534–539CrossRef

22.

Okumura K, Yasue H, Ishizaka H, Ogawa H, Fujii H, Yoshimura M (1992) Endothelium-dependent dilator response to substance P in patients with coronary spastic angina. J Am Coll Cardiol 20:838–844CrossRef

23.

Shimokawa H (2000) Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models. Jpn Circ J 64:1–12CrossRef

24.

Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Ogawa H, Kugiyama K, Saito Y, Miyamoto Y, Ogawa Y, Kaneshige T, Hiramatsu H, Yoshioka T, Kamitani S, Teraoka H, Nakao K (2000) Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786–%3eC and missense Glu298Asp variants. J Investig Med 48:367–374PubMed

25.

Herrmann J, Higano ST, Lenon RJ, Rihal CS, Lerman A (2004) Myocardial bridging is associated with alteration in coronary vasoreactivity. Eur Heart J 25:2134–2142CrossRef

26.

Ortega J, Hartman J, Rodriguez J, Maitland D (2008) Post-treatment hemodynamics of a basilar aneurysm and bifurcation. Ann Biomed Eng 36:1531–1546CrossRef

27.

Fry DL (1969) Certain histological and chemical responses of the vascular interface to acutely induced mechanical stress in the aorta of the dog. Circ Res 24:93–108CrossRef

28.

Ohyama K, Matsumoto Y, Takanami K, Ota H, Nishimiya K, Sugisawa J, Tsuchiya S, Amamizu H, Uzuka H, Suda A, Shindo T, Kikuchi Y, Hao K, Tsuburaya R, Takahashi J, Miyata S, Sakata Y, Takase K, Shimokawa H (2018) Coronary adventitial and perivascular adipose tissue inflammation in patients with vasospastic angina. J Am Coll Cardiol 71:414–425CrossRef

29.

Ohyama K, Matsumoto Y, Nishimiya K, Hao K, Tsuburaya R, Ota H, Amamizu H, Uzuka H, Takahashi J, Ito K, Shimokawa H (2016) Increased coronary perivascular adipose tissue volume in patients with vasospastic angina. Circ J 80:1653–1656CrossRef

30.

Maimaituxun G, Shimabukuro M, Fukuda D, Yagi S, Hirata Y, Iwase T, Takao S, Matsuura T, Ise T, Kusunose K, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Harada M, Sata M (2018) Local thickness of epicardial adipose tissue surrounding the left anterior descending artery is a simple predictor of coronary artery disease—new prediction model in combination with framingham risk score. Circ J 82:1369–1378CrossRef

31.

Masuda T, Ishikawa Y, Akasaka Y, Itoh K, Kiguchi H, Ishii T (2001) The effect of myocardial bridging of the coronary artery on vasoactive agents and atherosclerosis localization. J Pathol 193:408–414CrossRef

32.

Rogers IS, Tremmel JA, Schnittger I (2017) Myocardial bridges: overview of diagnosis and management. Congenit Heart Dis 12:619–623CrossRef

33.

Mok S, Majdalany D, Pettersson GB (2019) Extensive unroofing of myocardial bridge: a case report and literature review. SAGE Open Med Case Rep. https://doi.org/10.1177/2050313x18823380 CrossRefPubMedPubMedCentral

34.

Corban MT, Hung OY, Eshtehardi P, Rasoul-Arzrumly E, McDaniel M, Mekonnen G, Timmins LH, Lutz J, Guyton RA, Samady H (2014) Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies. J Am Coll Cardiol 63:2346–2355CrossRef

Title: Myocardial bridging is an independent predictor of positive spasm provocation testing by intracoronary ergonovine injections: a retrospective observational study
Authors: Riku Arai
Hiroto Kano
Shinya Suzuki
Hiroaki Semba
Takuto Arita
Naoharu Yagi
Takayuki Otsuka
Shunsuke Matsuno
Minoru Matsuhama
Yuko Kato
Tokuhisa Uejima
Yuji Oikawa
Yasuo Okumura
Junji Yajima
Takeshi Yamashita
Publication date: 01-04-2020
Publisher: Springer Japan
Published in: Heart and Vessels / Issue 4/2020
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI: https://doi.org/10.1007/s00380-019-01518-7

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Myocardial bridging is an independent predictor of positive spasm provocation testing by intracoronary ergonovine injections: a retrospective observational study

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2020

Predictive impact of early mobilization on rehospitalization for elderly Japanese heart failure patients

Changes of echocardiographic parameters in primary mitral regurgitation and determinants of symptom: an assessment from the Asian Valve Registry data

Ischemic stroke risk during post-discharge phases of heart failure: association of left ventricular concentric geometry

Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study

Different vascular healing process between bioabsorbable polymer-coated everolimus-eluting stents versus bioresorbable vascular scaffolds via optical coherence tomography and coronary angioscopy (the ENHANCE study: ENdothelial Healing Assessment with Novel Coronary tEchnology)

Clinical characteristics in patients with rest angina and hypoplastic right coronary artery

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page